Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Texas Immuno-Oncology Biorepository: Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers That Predict Benefit/Resistance to Cancer Therapeutics.

NCT05371756 is registered in ClinicalTrials.gov with Baylor Research Institute as lead sponsor.

NCT NCT05371756
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05371756 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Texas Immuno-Oncology Biorepository: Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers That Predict Benefit/Resistance to Cancer Therapeutics.
Lead sponsor
Baylor Research Institute
Phase
Observational
Overall status
Recruiting
Start date
September 11, 2020
Completion date
September 11, 2050
Enrollment
10,000 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

cancer